Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura B Jaeger

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Disease Models & Mechanisms|May 8, 2012
Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesisLaura B Jaeger, Avindra Nath
Methods in Molecular Medicine|September 18, 2004
Transport of antisense across the blood-brain barrierLaura B Jaeger, William A Banks
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Antisense therapeutics and the treatment of CNS diseaseLaura B Jaeger, William A Banks
Peptides|September 10, 2002
Effects of orexin-A on memory processingLaura B Jaeger, Susan A Farr, William A Banks, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2005
Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumorsLaura B Jaeger, William A Banks, Jozsef L Varga, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2007
Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administrationSan Ching, Hao Zhang, Natalya Belevych, et al.
Peptides|October 19, 2005
Preproenkephalin targeted antisenses cross the blood-brain barrier to reduce brain methionine enkephalin levels and increase voluntary ethanol drinkingWilliam A Banks, Laura B Jaeger, Akihiko Urayama, et al.
Brain, Behavior, and Immunity|June 3, 2009
Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's diseaseLaura B Jaeger, Shinya Dohgu, Rukhsana Sultana, et al.
Journal of Alzheimer'S Disease : JAD|May 13, 2009
Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognitionLaura B Jaeger, Shinya Dohgu, Mark C Hwang, et al.
Nature Neuroscience|February 24, 2006
Ghrelin controls hippocampal spine synapse density and memory performanceSabrina Diano, Susan A Farr, Stephen C Benoit, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Disease Models & Mechanisms|May 8, 2012
Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesisLaura B Jaeger, Avindra Nath
Methods in Molecular Medicine|September 18, 2004
Transport of antisense across the blood-brain barrierLaura B Jaeger, William A Banks
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Antisense therapeutics and the treatment of CNS diseaseLaura B Jaeger, William A Banks
Peptides|September 10, 2002
Effects of orexin-A on memory processingLaura B Jaeger, Susan A Farr, William A Banks, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2005
Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumorsLaura B Jaeger, William A Banks, Jozsef L Varga, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2007
Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administrationSan Ching, Hao Zhang, Natalya Belevych, et al.
Peptides|October 19, 2005
Preproenkephalin targeted antisenses cross the blood-brain barrier to reduce brain methionine enkephalin levels and increase voluntary ethanol drinkingWilliam A Banks, Laura B Jaeger, Akihiko Urayama, et al.
Brain, Behavior, and Immunity|June 3, 2009
Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's diseaseLaura B Jaeger, Shinya Dohgu, Rukhsana Sultana, et al.
Journal of Alzheimer'S Disease : JAD|May 13, 2009
Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognitionLaura B Jaeger, Shinya Dohgu, Mark C Hwang, et al.
Nature Neuroscience|February 24, 2006
Ghrelin controls hippocampal spine synapse density and memory performanceSabrina Diano, Susan A Farr, Stephen C Benoit, et al.
Pageof 1